Does the 2004 ISHLT revision improve concordance among pathologists for grading cardiac allograft rejection?
The 2004 ISHLT grading system for endomyocardial biopsies shows poor inter-pathologist agreement for higher grades, suggesting it should not be used in isolation for clinical decisions.
The 2004 revision has done little to improve agreement on the higher ISHLT grades. An EMB grade ≥2R is not by itself sufficient as a basis for clinical decisions or as a research criterion. Steps should be taken toward greater uniformity in EMB grading, and efforts should be made to replace the ISHLT classification with diagnostic criteria--EMB based or otherwise--that correspond better with the pathophysiology of the transplanted heart.
Crespo‐Leiro et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: